Page last updated: 2024-11-07

nuclear yellow

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nuclear yellow: RN from 10th CI, Chem Subs Index; RN refers to tri-HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123837
MeSH IDM0111302

Synonyms (18)

Synonym
4-[5-(4-methylpiperazin-1-yl)-1h,1'h-2,5'-bibenzimidazol-2'-yl]benzenesulfonamide trihydrochloride
nuclear yellow
74681-68-8
HY-15619
CS-1304
hoechst s 769121
hoe-s769121
4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1h-benzimidazol)-2'-yl)benzenesulfonamide trihydrochloride
DTXSID30996200
4-[6-(4-methylpiperazin-1-yl)-1h,1'h-[2,5'-bibenzimidazol]-2'-yl]benzene-1-sulfonamide--hydrogen chloride (1/3)
F84922
MS-30589
4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]benzenesulfonamide;trihydrochloride
ZCA68168
4-(5-(4-methylpiperazin-1-yl)-1h,1'h-[2,5'-bibenzo[d]imidazol]-2'-yl)benzenesulfonamide trihydrochloride
A915636
nuclearyellow
AKOS040744103

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (89)

TimeframeStudies, This Drug (%)All Drugs %
pre-199056 (62.92)18.7374
1990's26 (29.21)18.2507
2000's7 (7.87)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.73 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.05 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other89 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]